Top Stories
Axis Bank approves ₹20,000 crore equity fundraise via QIP, other routes Axis Bank Q4 FY26 results: Profit at ₹7,071 crore beats estimates; NII misses, asset quality improves L&T Finance Q4 FY26 results: Net profit rises 26.8%, NII up 24.8%; board recommends ₹2.75 dividend Why are Anant Raj Shares Falling 8% Today? Explained Hindustan Zinc Q4 FY26 results: Profit rises to ₹5,033 crore, revenue jumps 49% YoY; margins expand Adani Green Q4 FY26 Results: Profit jumps 73% YoY; margin expands to 82.3% Chennai Petroleum Q4 FY26 results: Profit surges 42% QoQ while margin expands to 12.1%; Rs 54 dividend announced Cipla faces $100 million revenue risk as USFDA alert delays restart beyond FY27, says Macquarie Axis Bank approves ₹20,000 crore equity fundraise via QIP, other routes Axis Bank Q4 FY26 results: Profit at ₹7,071 crore beats estimates; NII misses, asset quality improves L&T Finance Q4 FY26 results: Net profit rises 26.8%, NII up 24.8%; board recommends ₹2.75 dividend Why are Anant Raj Shares Falling 8% Today? Explained Hindustan Zinc Q4 FY26 results: Profit rises to ₹5,033 crore, revenue jumps 49% YoY; margins expand Adani Green Q4 FY26 Results: Profit jumps 73% YoY; margin expands to 82.3% Chennai Petroleum Q4 FY26 results: Profit surges 42% QoQ while margin expands to 12.1%; Rs 54 dividend announced Cipla faces $100 million revenue risk as USFDA alert delays restart beyond FY27, says Macquarie
Business Desk
AUTHOR

Business Desk

Business Desk for online coverage of corporate filing on stock exchanges.

COVERS
Business Corporates
LATEST
BUSINESS

Alembic Pharmaceuticals receives USFDA approval for Fingolimod Capsules with market size of US$ 145 million

Alembic Pharmaceuticals secures USFDA approval for Fingolimod Capsules, estimated market size of US$ 145 million. The company has 237 ANDA…

Apr 25, 2026
blank
1 … 44 45 46 47 48 … 92